scPharmaceuticals Ownership | Who Owns scPharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

scPharmaceuticals Ownership Summary

scPharmaceuticals is owned by 18.36% institutional investors, 6.08% insiders, and 75.56% retail investors. Orbimed advisors is the largest institutional shareholder, holding 13.61% of SCPH shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.26% of its assets in scPharmaceuticals shares.

SCPH Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	scPharmaceuticals	18.36%	6.08%	75.56%
Sector	Healthcare Stocks	279.19%	10.58%	-189.76%
Industry	Biotech Stocks	63.97%	10.68%	25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	6.06M	13.61%	$15.94M
Rubric capital management lp	4.78M	10.26%	$16.90M
Aigh capital management	4.17M	8.97%	$14.78M
King luther capital management	2.86M	6.14%	$10.12M
Blackrock funding, inc. /de	2.28M	4.90%	$8.08M
Blackrock	1.77M	4.54%	$7.69M
Vanguard group	2.11M	4.53%	$7.46M
J. goldman & co lp	1.22M	2.62%	$4.32M
5am venture management	1.20M	2.58%	$4.25M
Nantahala capital management	995.44K	2.24%	$2.62M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aigh capital management	4.17M	4.62%	$14.78M
Stonepine capital management	683.53K	1.95%	$2.42M
Tejara capital	612.85K	1.42%	$2.17M
5am venture management	1.20M	1.01%	$4.25M
Apis capital advisors	504.95K	0.64%	$1.33M
Kingdon capital management	800.00K	0.40%	$2.83M
Orbimed advisors	6.06M	0.38%	$15.94M
Rubric capital management lp	4.78M	0.22%	$16.90M
Balanced rock investment advisor	70.36K	0.20%	$249.08K
Rice hall james & associates	989.63K	0.19%	$3.50M

Top Buyers

Holder	Shares	% Assets	Change
Ubs group	1.04M	0.00%	1.02M
King luther capital management	2.86M	0.04%	632.12K
Blackrock funding, inc. /de	2.28M	0.00%	429.42K
Vanguard group	2.11M	0.00%	399.51K
Rice hall james & associates	989.63K	0.19%	367.97K

Top Sellers

Holder	Shares	% Assets	Change
Suvretta capital management	-	-	-1.84M
Velan capital investment management lp	-	-	-517.67K
Walleye capital	-	-	-475.56K
Bank of montreal /can/	-	-	-351.81K
Monashee investment management	-	-	-319.80K

New Positions

Holder	Shares	% Assets	Change	Value
Raymond james financial	89.69K	0.00%	89.69K	$317.50K
Johnson financial group	85.18K	0.04%	85.18K	$301.55K
Cubist systematic strategies	28.76K	0.00%	28.76K	$75.64K
Price t rowe associates inc /md/	15.14K	-	15.14K	$54.00K
Proshare advisors	13.46K	0.00%	13.46K	$47.67K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-6.00
Farther finance advisors	-59.00
Capital performance advisors llp	-85.00
Covestor	-151.00
Gamma investing	-265.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	6	-93.10%	8,173,062	-79.45%	18	0.25%	2	-96.30%	2	-87.50%
Dec 31, 2024	82	-16.33%	39,015,482	4.73%	83	1.31%	49	-19.67%	16	-15.79%
Sep 30, 2024	97	21.25%	37,237,619	33.87%	79	1.57%	60	46.34%	19	-20.83%
Jun 30, 2024	79	-2.47%	27,815,248	4.03%	71	1.50%	41	17.14%	23	-23.33%
Mar 31, 2024	81	-4.71%	26,737,984	-4.32%	68	1.33%	35	-16.67%	30	20.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.14M	2.26%	-
Vanguard Total Stock Mkt Idx Inv	1.14M	2.26%	-
iShares Russell 2000 ETF	920.25K	1.74%	450.00
Vanguard Institutional Extnd Mkt Idx Tr	532.69K	1.06%	-
Fidelity Small Cap Index	380.49K	0.76%	10.65K
iShares Russell 2000 Growth ETF	328.10K	0.62%	-
Kennedy Micro Cap	218.81K	0.44%	1.05K
State St Russell Sm/Mid Cp® Indx NL Cl C	212.85K	0.42%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	212.85K	0.42%	-
Vanguard Russell 2000 ETF	192.41K	0.38%	10.86K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 13, 2024	ORBIMED ADVISORS LLC	-	Buy	$86.63K
Aug 13, 2024	ORBIMED ADVISORS LLC	-	Buy	$1.91M
Nov 25, 2022	ORBIMED ADVISORS LLC	-	Buy	$4.00M
Oct 06, 2022	5AM Partners IV, LLC	-	Sell	$152.89K
Oct 06, 2022	Schwab Andrew J.	-	Sell	$152.89K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q3	2	-
2024 Q2	-	-
2024 Q1	-	-

SCPH Ownership FAQ

Who Owns scPharmaceuticals?

scPharmaceuticals shareholders are primarily institutional investors at 18.36%, followed by 6.08% insiders and 75.56% retail investors. The average institutional ownership in scPharmaceuticals's industry, Biotech Stocks , is 63.97%, which scPharmaceuticals falls below.

Who owns the most shares of scPharmaceuticals?

scPharmaceuticals’s largest shareholders are Orbimed advisors (6.06M shares, 13.61%), Rubric capital management lp (4.78M shares, 10.26%), and Aigh capital management (4.17M shares, 8.97%). Together, they hold 32.83% of scPharmaceuticals’s total shares outstanding.

Does Blackrock own scPharmaceuticals?

Yes, BlackRock owns 4.54% of scPharmaceuticals, totaling 1.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.69M$. In the last quarter, BlackRock decreased its holdings by -32.941K shares, a -1.83% change.

Who is scPharmaceuticals’s biggest shareholder by percentage of total assets invested?

Aigh capital management is scPharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.62% of its assets in 4.17M scPharmaceuticals shares, valued at 14.78M$.

Who is the top mutual fund holder of scPharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of scPharmaceuticals shares, with 2.26% of its total shares outstanding invested in 1.14M scPharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools